Abbott Laboratories (ABT): Dividends Paid
$4.12B
Year ended 2025-12-31
$4.19B
Trailing 12 months to 2026-03-31
+7.5%
3-year compound annual growth
+10.0%
5-year compound annual growth
+11.1%
10-year compound annual growth
| Period ended | Dividends Paid | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.12B | +7.3% | 2026-02-20, From 2025-01-01 |
| 2024-12-31 | $3.84B | +7.9% | 2026-02-20, From 2024-01-01 |
| 2023-12-31 | $3.56B | +7.5% | 2026-02-20, From 2023-01-01 |
| 2022-12-31 | $3.31B | +3.3% | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $3.20B | +25.1% | 2024-02-16, From 2021-01-01 |
| 2020-12-31 | $2.56B | +12.8% | 2023-02-17, From 2020-01-01 |
| 2019-12-31 | $2.27B | +15.0% | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | $1.97B | +6.8% | 2021-02-19, From 2018-01-01 |
| 2017-12-31 | $1.85B | +20.1% | 2020-02-21, From 2017-01-01 |
| 2016-12-31 | $1.54B | +6.7% | 2019-02-22, From 2016-01-01 |
| 2015-12-31 | $1.44B | +7.5% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $1.34B | +52.2% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $882.00M | -72.3% | 2016-02-19, From 2013-01-01 |
| 2012-12-31 | $3.18B | +8.3% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $2.94B | +10.0% | 2014-02-21, From 2011-01-01 |
| 2010-12-31 | $2.67B | +10.6% | 2013-02-15, From 2010-01-01 |
| 2009-12-31 | $2.41B | +11.0% | 2012-02-21, From 2009-01-01 |
| 2008-12-31 | $2.17B | +11.0% | 2011-02-18, From 2008-01-01 |
| 2007-12-31 | $1.96B | n/a | 2010-02-19, From 2007-01-01 |
Dividends Paid at similar companies
| Company | Year ended | Dividends Paid | Change YoY |
|---|---|---|---|
| Abbott Laboratories (ABT) | 2025-12-31 | $4.12B | +7.3% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $5.04B | +3.7% |
| AbbVie Inc. (ABBV) | 2025-12-31 | $11.66B | +5.7% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $8.18B | +4.3% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $5.38B | +15.0% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $370.30M | n/a |
| Organon & Co. (OGN) | 2025-12-31 | $88.00M | -70.4% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $159.30M | +4.5% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $19.46M | +0.1% |
Compare ABT, BMY, ABBV, MRK side by side · Screen every company in Pharmaceutical Preparations ↗